People

Rada Savic, PhD

Professor
Bioengineering

My research uses computational methods to study the dynamic interplay between disease progression, treatment regimen, and drug and biomarker response across relevant scales (molecule, cell, tissue, organ & whole body) to determine causal links underlying variability in (safety and efficacy) clinical outcomes. By integrating multi-scale, and multi-level clinical data, we aim to determine the right dose, schedule, and treatment duration of various therapies, potentially bringing novel, precise and personalized treatment options to patients with unmet need more quickly.

Anne Schafer, MD

Professor In Residence
Medicine

Dr. Schafer is Professor of Medicine and of Epidemiology & Biostatistics at UCSF and Chief of Endocrinology and Metabolism at the San Francisco VA Health Care System. She is board-certified by the American Board of Internal Medicine in the subspecialty of Endocrinology, Diabetes and Metabolism. Her research focus is osteoporosis and bone metabolism. One of her research emphases is osteoporosis treatment and the assessment of response to osteoporosis therapy.

Tiffany Scharschmidt, MD

Associate Professor
Dermatology

Pasang Nuru Sherpa, BS

Lead Research Administrator
Medicine

Sanyog Shitole, MBBS, MPH

Assistant Professor
Medicine

Anita Sil, MD, PhD

Professor-HCOMP
Microbiology and Immunology

Marina Sirota, PhD

Professor In Residence
Pediatrics

Marina is currently a Professor and the Acting Director at the Bakar Computational Health Sciences Institute at UCSF. Prior to that she has worked as a Senior Research Scientist at Pfizer where she focused on developing Precision Medicine strategies in drug discovery. She completed her PhD in Biomedical Informatics at Stanford University. Dr. Sirota’s research experience in translational bioinformatics spans nearly 20 years during which she has co-authored over 170 scientific publications.

Ma Somsouk, MD, MAS

Professor
Medicine

1. Programmatic implementation of population-based colorectal cancer screening and follow-up of abnormal screening results. We embrace big data and technology to design, develop, and deliver economic and effective services for patients and health systems.

2. Use of human gut samples to study HIV, Covid-19, barrier function, systemic inflammation, inflammatory bowel disease, and microbiome. Approaches employed: organoid models, isolation of epithelial cells and lymphocytes, single cell, spatial transcriptomic analysis, microbial profiling, and blood-based profiling.

Paola Soto Perez

Graduate Student
Microbiology & Immunology

Matthew Spitzer, PhD

Associate Professor
Otolaryngology-Head and Neck Surgery

The Spitzer Lab is working to develop our understanding of how the immune system coordinates its responses across the organism with an emphasis on tumor immunology. We combine methods in experimental immunology and cancer biology with computation to understand the modes in which the immune system can respond to tumors and to rationally initiate curative immune responses against cancer.

Natasha Spottiswoode, MD, PhD

Assistant Prof of Clin Med
Medicine

Infectious disease physician-scientist with a focused on unbiased diagnostics and developing treatments for uncommon infections.

Kristina Stillwell, MD

HS Assoc Clinical Professor
Pediatrics

Pages